| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/15/2001 | CA2408921A1 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 11/15/2001 | CA2408840A1 Myc targets |
| 11/15/2001 | CA2408828A1 Novel serine-threonine kinase-4 |
| 11/15/2001 | CA2408767A1 Method and device for prepaping polynucleotide microarray and polynucleotide microarray |
| 11/15/2001 | CA2408738A1 Virulence genes, proteins, and their use |
| 11/15/2001 | CA2408732A1 Modified es cells and es cell-specific gene |
| 11/15/2001 | CA2408665A1 Novel regulator of g protein signalling |
| 11/15/2001 | CA2408664A1 F-box containing protein |
| 11/15/2001 | CA2408652A1 A method for designing and screening random libraries of compounds |
| 11/15/2001 | CA2408634A1 Hypha-specific factors from candida albicans |
| 11/15/2001 | CA2408632A1 Ph domain-interacting protein |
| 11/15/2001 | CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 11/15/2001 | CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof |
| 11/15/2001 | CA2408468A1 Serine-threonine kinase-3 |
| 11/15/2001 | CA2408306A1 Method for detecting and identifying the presence of biological substances derived from birds, and oligonucleotides therefor |
| 11/15/2001 | CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents |
| 11/15/2001 | CA2408268A1 Identifying clusters of transcription factor binding sites |
| 11/15/2001 | CA2408253A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 11/15/2001 | CA2408213A1 Protein complexes and assays for screening anti-cancer agents |
| 11/15/2001 | CA2408196A1 Sphingosine kinase and uses thereof |
| 11/15/2001 | CA2408166A1 Presenilin enhancers |
| 11/15/2001 | CA2408148A1 Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof |
| 11/15/2001 | CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 11/15/2001 | CA2408038A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 11/15/2001 | CA2408010A1 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene |
| 11/15/2001 | CA2408002A1 Enzymatic assays for screening anti-cancer agents |
| 11/15/2001 | CA2407955A1 Genes of the 1-desoxy-d-xylulose biosynthesis path |
| 11/15/2001 | CA2407937A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 11/15/2001 | CA2407865A1 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders |
| 11/15/2001 | CA2407864A1 Lipid metabolism enzymes |
| 11/15/2001 | CA2407850A1 Cytoskeleton-associated proteins |
| 11/15/2001 | CA2406691A1 Methods for making nucleic acids |
| 11/15/2001 | CA2406644A1 Sentinel virus ii |
| 11/15/2001 | CA2334827A1 Trypsin substrate and diagnostic device, and method of using same |
| 11/15/2001 | CA2334321A1 Urinary trypsin inhibitor assay containing a chelating agent |
| 11/14/2001 | EP1154443A1 Magnetic glass particles, method for their preparation and uses thereof |
| 11/14/2001 | EP1154019A2 G-protein coupled receptor (HFGAN72X) |
| 11/14/2001 | EP1154015A2 Yeast and process for producing bread |
| 11/14/2001 | EP1153302A1 Diagnostics and therapeutics for macular degeneration |
| 11/14/2001 | EP1153301A1 Diagnostics and therapeutics for arterial wall disruptive disorders |
| 11/14/2001 | EP1153295A2 Structure-based screening techniques for drug discovery |
| 11/14/2001 | EP1153141A2 HIGH DENSITY SAMPLING OF DIFFERENTIALLY EXPRESSED PROKARYOTIC mRNA |
| 11/14/2001 | EP1153140A1 Protection probes |
| 11/14/2001 | EP1153139A2 Polymorphic markers of the lsr gene |
| 11/14/2001 | EP1153138A1 Detection of cells using the luciferase/luciferin reaction |
| 11/14/2001 | EP1153137A2 High-throughput toxicological testing using cultured organisms and cells |
| 11/14/2001 | EP1153133A2 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same |
| 11/14/2001 | EP1153129A1 Method of treating restenosis by antisense targeting of c-myc |
| 11/14/2001 | EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation |
| 11/14/2001 | EP1153036A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 11/14/2001 | EP1153035A2 Human lipid-associated proteins |
| 11/14/2001 | EP1152821A1 Method for producing addressed ligand matrixes on a support |
| 11/14/2001 | EP1152764A1 Compositions and methods for use in targeting vascular destruction |
| 11/14/2001 | EP1058738B1 A fluorescence polarization screening method |
| 11/14/2001 | EP1053355B1 Pna and dna conjugates and methods for preparation thereof |
| 11/14/2001 | EP0918885A4 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 11/14/2001 | EP0904411B1 Passive internal references for the detection of nucleic acid amplification products |
| 11/14/2001 | EP0695344B1 Peroxidase colloidal gold oxidase biosensors for mediatorless glucose determination |
| 11/14/2001 | EP0689675B1 Method for differentiating the source of occult gastrointestinal bleeding |
| 11/14/2001 | EP0484369B1 Modified bioluminescent proteins and their use |
| 11/14/2001 | CN1322255A Method for determining alkaline phosphatase |
| 11/14/2001 | CN1322254A Small volume (in vitro) analyte sensor with diffusible or non-leachable redox mediator |
| 11/14/2001 | CN1322251A Mutant human hepatitis B viral strain and uses thepeof |
| 11/14/2001 | CN1322248A Plant disease resistance signalling gene, mateirals and methods relating thereto |
| 11/14/2001 | CN1322246A Restin and methods of use thereof |
| 11/14/2001 | CN1322213A Treatment of inflammatory disease |
| 11/14/2001 | CN1321890A Nucteic acid amplification gene chip hybridization detecting instrument |
| 11/14/2001 | CN1321776A Method for detecting biological molecule by means of multiple in situ amplification of nanometer gold particles |
| 11/14/2001 | CN1321775A External dialysis tube method for determining degestion rate of feed protein and amino acid |
| 11/14/2001 | CN1321774A G protein coupled acceptor protein, its production method and use |
| 11/14/2001 | CN1321773A Method for determining influence of growth changing agent on microbe colony |
| 11/14/2001 | CN1321760A Novel polypeptide-human striatum concentrated phosphatase (STEP) 11 and polynucleotide for coding this polypeptide |
| 11/14/2001 | CN1321759A Novel polypetpide-human uridylic acid kinase 11 and polynucleotide for coding for polypeptide |
| 11/14/2001 | CN1321754A Novel polypeptide-human YSK 1 protein kinase 14 and polynucleotide for coding this polypeptide |
| 11/14/2001 | CN1321749A Novel polypeptid-human tyrosinase 8 and polynucleotide for coding this polypeptide |
| 11/14/2001 | CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma |
| 11/13/2001 | US6316692 Insertion of nucleotide sequences into genomes; inject sample into testes, recover preferential polypeptide from transformed cells |
| 11/13/2001 | US6316626 Amine compounds and combinatorial libraries comprising same |
| 11/13/2001 | US6316611 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 11/13/2001 | US6316608 Polynucleotides; for use in dection and measurement of preferential particles in sample |
| 11/13/2001 | US6316607 Electrochemiluminescent assays |
| 11/13/2001 | US6316603 Modifications of the VEGF receptor-2 protein and methods of use |
| 11/13/2001 | US6316416 Uteroglobin therapy for epithelial cell cancer |
| 11/13/2001 | US6316273 Apparatus for monitoring preferential particles in solution |
| 11/13/2001 | US6316266 Sample presentation apparatus for mass spectrometry |
| 11/13/2001 | US6316263 Method for measuring antioxidant activities of samples and method for diagnosing diabetes or hyperlipidemia using the same |
| 11/13/2001 | US6316239 HKABY60 kinase family polypeptides |
| 11/13/2001 | US6316238 Process for producing activated human ALT |
| 11/13/2001 | US6316237 Respiratory nitrate reductase alpha subunit |
| 11/13/2001 | US6316230 Polymerase extension at 3′ terminus of PNA-DNA chimera |
| 11/13/2001 | US6316229 Single molecule analysis target-mediated ligation of bipartite primers |
| 11/13/2001 | US6316219 Compounds |
| 11/13/2001 | US6316215 Methods of cancer screening utilizing fluorescence detection techniques and selectable imager charge integration periods |
| 11/13/2001 | US6316213 Methods for the early diagnosis of ovarian, breast and lung cancer |
| 11/13/2001 | US6316206 Method for screening comprising cells expressing the CNTF receptor |
| 11/13/2001 | US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 11/13/2001 | US6316202 Nucleic acids encoding cold sensitive mutant DNA polymerases |
| 11/13/2001 | US6316200 Monitoring target nucleotide sequences; generate adaptor nucleotide sequences, hybridize reporter molecules to nucleotide sequences, detect hybridization products |
| 11/13/2001 | US6316198 Detection of mutations in genes by specific LNA primers |
| 11/13/2001 | US6316196 Methods for analyzing LTC4 synthase polymorphisms and diagnostic use |